Risk factors for the development of an early recurrence of gemistocytic astrocytomas and their clinical significance

Author:

Zrelov A. A.1,Nechaeva A. S.2

Affiliation:

1. Polenov Neurosurgical Research Institute, branch of the Almazov National Medical Research Centre

2. Polenov Neurosurgical Research Institute, branch of the Almazov National Medical Research Centre; World-Class Research Centre for Personalized Medicine

Abstract

Introduction. According to the WHO CNS of tumors of central nervous system gemistocytic astrocytomas (GA) are common astrocytic tumors, in which the proportion of gemistocytes is at least 20 % of the total cell mass. Morpho-molecular characterization and treatment tactics of GA research is insufficient.Purpose. Identification of risk factors for the development of early recurrence of gemistocytic astrocytes (GA).Material and methods. A retrospective and prospective analysis of the identified signs, brain MRI data, features of morphological and molecular genetic diseases was performed in 14 patients diagnosed with GA. The work included patients older than 18 years with supratentorial invasive tumor. The patients were aged 27 to 62 years, the average temperature of the age was 35.5 years. There were 5 men. After the removal operation, histological, immunohistochemical and molecular genetic studies were performed. The histological diagnosis was made according to the WHO classification of CNS tumors and the AFIP atlas (2007). Real-time PCR revealed the presence of mutations in the IDH1/IDH2 genes and the combined deletion of 1p19q in all patients; in 10 patients, the level of gene expression was also observed: TP, VEGF, PDGFRA, β-tubulin, MGMT, C-kit, ERCC1.Results. Median recurrence-free period (RFS) GA was 89 weeks. If a recurrence occurs before this time RFS is considered early. The odds ratio (OR) was calculated for different groups of early and late recurrence according to the standard method. Significantly, the risk of developing an early relapse of GA increased with the expression of the VEGF gene, ΔSt < 1.15 (p < 0.05) (OR — 121). Several risk factors were also identified that cause inflammation of GA recurrence, but without a statistical tumor: expression of the β-tubulin gene ΔSt < 0.65 (RR — 33), accumulation of tumor contrast. according to MRI of the brain (OR — 10.7), vascular proliferation (OR — 8.3), Ki-67 > 5 % (OR — 4.5), tumor spread in the area of opening of the cerebral hemispheres (OR — 4.5).Conclusion. Features of brain MRI data, morphological and molecular-genetic picture These patients probably need complex treatment (surgery, radiation therapy, chemotherapy), which they currently do not meet.

Publisher

Arterialnaya Gipertenziya

Reference34 articles.

1. Khachatryan VA, Ulitin AYu, Samochernykh KA, et al. Medulloblastoma (literature review). Part I. Epidemiology. Pathomorphology. Diagnostics. Neurosurgery and neurology of childhood. 2013;4(38):59–70. In Russian

2. Melchenko SA, Ulitin AYu, Olyushin VE, et al. Multiple gliomas of the brain (literature review). Russian neurosurgical journal. n.a. prof. A. L. Polenov. 2015;S2:98–99. In Russian

3. Bazhanov SP, Olyushin VE, Ulitin AYu. Specific antitumor immunotherapy in the complex treatment of patients with malignant supratentorial tumors. Siberian journal of oncology. 2009;6:23–27. In Russian

4. WHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on Cancer; 2021, WHO classification of tumours series, 5th ed.; vol. 6. https://tumourclassification.iarc.who.int/chapters/45.

5. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology. 2005;64(6):479–489. DOI: 10.1093/jnen/64.6.479.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3